Eli Lilly and Company · 13 hours ago
Computational Biologist – Obesity Research
Boston, MA
Full-time
Onsite
Mid, Senior Level
$138K/yr - $224K/yr
2+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, focused on discovering and bringing life-changing medicines to those in need. The role of Computational Biologist within the Diabetes, Obesity and Complications Therapeutic Area involves applying computational and statistical approaches to analyze multi-omics data, aiming to drive therapeutic discovery in metabolic diseases and obesity.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Design and complete studies using omics-related data sources, including RNA-seq, spatial transcriptomics, single-cell omics, proteomics, functional genomics, metabolomics, and more
Integrate standard analytical approaches as well as emerging AI/ML models to answer scientific questions of high-dimensional data
Partner with discovery statistics team to create novel analytical frameworks for high-throughput studies and develop specialized methodologies to enhance insights from small-sample datasets
Stay up-to-date on current technical and scientific advances through deep understanding of the literature and attendance of relevant technical and disease-related conferences
Clearly communicate complex results to cross-functional partners in a prompt and transparent manner
Perform ad-hoc bioinformatics analyses and data visualizations as needed
Work collaboratively with other Data Sciences and Computational Biology (DSCB) scientists to develop innovative, best in class computational workflows and data repositories for advanced analyses
Engage in code and documentation review within the team and across other teams within the DSCB team
Adhere to industry-standard protocols for scientific project documentation
Qualification
Required
PhD or equivalent in Computational Biology, Bioinformatics, Biomedical Informatics, or related field with 2+ years of experience post-PhD in relevant disease area
Strong track record of execution of computational biology and/or bioinformatics-based projects, potentially including RNA-seq, metabolomics, multi-omics, human genetics, proteomics, AI/ML, and other related research modalities required
Expertise in programming languages including R and Python and experience with workflow management systems such as Nextflow required
Ability to prioritize and manage multiple competing priorities within a fast-paced environment required
The ability to communicate complex scientific and computational concepts to non-computational and non-scientist audiences required
Ability to represent the DOCTA DSCB team internally and externally required
Strongly team-oriented thinking mentality required
Preferred
Prior experience and deep expertise in obesity and related areas, preferably with data from preclinical models, patient cohorts or cell lines preferred
Experience developing production-grade bioinformatics pipelines, including working with standardized workflow tools preferred
Experience with implementation and maintenance of industry-standard documentation practices including Git, Confluence, JIRA, or equivalent preferred
Prior industry experience preferred
Experience with scalable cloud computing platforms (e.g. Databricks, AWS) and big data analytics frameworks preferred
Experience with containerized technologies (e.g. Docker) for computational reproducibility preferred
Knowledge of human genetics preferred
Benefits
Company bonus
Company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
The Motley Fool
2026-01-25
2026-01-24
2026-01-23
Company data provided by crunchbase